Purchase Order 12305B21P0154
- Not listed
- The U.S. government awarded a firm fixed-price purchase order valued at $9,808.00 to 10X Genomics, Inc. for one Chromium Genome Chip Kit V2 (48 reactions) on September 19, 2017. The contract, which was performed in Pleasanton, California, carried an ultimate completion date of October 18, 2017. No set-aside designation was applied to this procurement, and the funding was provided by a civilian federal agency within the Southeast Area. 10X Genomics, Inc., a biotechnology company specializing in...
- This is a firm fixed price purchase order awarded by the Northeast Area of a civilian federal agency to 10X Genomics, Inc. for $21,888.50. The award is for 10X Genomics Chromium consumables to support single cell sequencing. The contract has no set-aside designation and is intended to supply these genomics products and services to support the agency's biomedical research efforts, particularly by the National Institutes of Health and its various institutes and centers. 10X Genomics is a life...
- This is a firm fixed-price purchase order awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to 10X Genomics, Inc. as the prime contractor. The $52,750.00 contract is for the delivery of 10X Genomics' products and services related to single-cell and spatial analysis applications, including specialized kits, instruments, and associated installation, training, maintenance, and support. The end date for the contract is August 8, 2025. This award is not associated with...
- This firm fixed price purchase order was awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to 10X Genomics, Inc. for the delivery of genomic analysis products and services. The contract has a ceiling value of $25,143.00 and a period of performance ending on July 24, 2025. 10X Genomics, a for-profit manufacturer, is providing specialized kits, instruments, and associated services to support biomedical research, primarily for the National Institutes of Health....
- This firm fixed-price purchase order was awarded by the Shared Services Center, a civilian federal agency, to 10X Genomics, Inc. for the provision of reagents for the generation of spatially resolved transcriptomics. The contract, valued at $76,716.60, has a 15-day delivery timeline and an ultimate completion date of August 12, 2021. No set-aside designation was used. 10X Genomics is a life sciences technology company that specializes in products and services for single-cell and spatial analysis...
- This is a $45,335.00 firm fixed price purchase order awarded by the National Institute of Environmental Health Sciences, a civilian agency, to 10X Genomics, Inc., a for-profit manufacturer headquartered in Pleasanton, California. The contract is for the delivery of epigenomics laboratory reagents to support spatial sequencing gene expression research. No set-aside was used. 10X Genomics is a leading provider of advanced genomic analysis platforms, instruments, and bioinformatics software to...
- This is a federal contract award to 10X Genomics, Inc., a biotechnology company in Pleasanton, California, for the procurement of laboratory supplies. The contract has a ceiling value of $34,810.59 and a performance period ending on September 11, 2026. The contract is a purchase order with a firm fixed-price pricing type, awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency. The contract does not have a set-aside designation. 10X Genomics is the prime...
- 10X Genomics, Inc. was awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $21,328.04 by the Office of Logistics and Acquisition Operations on September 19, 2022, with completion expected by October 19, 2022. The contract, which carries no set-aside designation, will be performed in Westport, California. As a specialized biotechnology company headquartered in Pleasanton, California, 10X Genomics supplies advanced genomic analysis platforms, reagents, and bioinformatics...
- 10X Genomics, Inc. received a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $10,805.00 from the Office of Logistics and Acquisition Operations on August 12, 2022, with an ultimate completion date of March 31, 2023. The contract, which carries no set-aside designation, supports the contractor's supply of specialized genomic analysis products and services from its Pleasanton, California headquarters. As a leading biotechnology firm, 10X Genomics provides advanced genomic...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development, a civilian federal agency, to 10X Genomics, Inc., a biotechnology company in Pleasanton, California. The $9,999.00 order is for the Chromium Next GEM product, which is used for advanced single-cell and spatial genomic analysis. 10X Genomics has been awarded multiple federal contracts and task orders from NIH institutes, often with small business set-aside designations, to provide...
The U.S. government awarded a purchase order valued at $22,816.72 to 10X Genomics, Inc. on June 25, 2021, with an ultimate completion date of August 4, 2021. This firm fixed-price contract, which includes $100 in shipping charges, was funded by a civilian federal agency within the Northeast Area and references Quote No. SQ3114069V1 provided by John Cigoni on May 27, 2021. The work is to be performed in Orient, New York. No set-aside designation was used for this procurement. 10X Genomics, Inc., a biotechnology company headquartered in Pleasanton, California, specializes in advanced genomic analysis platforms, reagents, instruments, and bioinformatics software for single-cell and spatial transcriptomics research. The company maintains an extensive contract history with federal agencies, particularly the National Institutes of Health, providing sophisticated genomic analysis products including Chromium Next GEM Single Cell Kits, Visium Spatial Gene Expression systems, and related consumables. This purchase order represents one of numerous federal procurements supporting biomedical research efforts across the government, consistent with the company's established role as a critical supplier of advanced genomic analysis technologies to federal research institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.8k | 7/6/21 |